Dutch regulator intervenes to encourage biosimilars competition

A regulatory intervention in the Netherlands has put an end to a discounting scheme for a popular medicine in a bid to make it easier for biosimilar products to compete in the market.

Read Complete Article

MITLA is a member of the INPLP

    Subscribe for the latest
    IT Law updates

    Receive the latest IT Law updates straight to your inbox, gain access to our exclusive industry events, keep up to date with MITLA.